3657 results for «213»
3657 results
CTO PCI
19 Dec 2024 – From GulfPCR-GIM 2024
Embark on a journey to master Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) procedures. This comprehensive session will prepare your mindset, equip you with strategies to avoid failure, and provide valuable insights from real-world CTO case failures. Explore techniques to effectively deal with CTO procedure...
Femoropopliteal intervention
18 Dec 2024 – From GulfPCR-GIM 2024
This session provides an in-depth look at femoropopliteal intervention, covering the updated PAD guidelines, step-by-step approaches for peripheral interventions based on clinical scenarios, the essential toolbox for performing femoropopliteal endovascular procedures, and effective techniques for managing wide bore femoral access complications. Gain comprehensive insights to optimize...
Left main PCI strategies for bifurcations and trifurcations
19 Dec 2024 – From GulfPCR-GIM 2024
Explore this comprehensive session on left main PCI strategies for bifurcations and trifurcations. Discover techniques such as the triple kissing balloon inflation technique in a complex distal LM trifurcation lesion, imaging-guided multivessel PCI to left anterior descending CTO and left main bifurcation, and IVUS-guided PCI to...
Challenging structural interventions #1
18 Dec 2024 – From GulfPCR-GIM 2024
Prepare to be captivated by a collection of challenging structural interventions showcased in this session. Witness the ingenuity of interventional cardiologists as they tackle complex cases, from TMVR with laceration of the anterior mitral leaflet to percutaneous closure of sinus of Valsalva aneurysm rupture. Discover how...
Caught between a calcified rock and a hard place
19 Dec 2024 – From GulfPCR-GIM 2024
This session delves into the challenges of managing heavily calcified coronary lesions, particularly in complex scenarios like left main bifurcation angioplasty and in elderly patients with unstable angina. Explore innovative techniques to tackle abrupt vessel closure, situations where rotablation may fall short, and state-of-the-art approaches for...
Complications and challenging cases #2
19 Dec 2024 – From GulfPCR-GIM 2024
Dive into this session to explore a collection of challenging cases and complications encountered in interventional cardiology. From a ruptured balloon inside a coronary artery to a percutaneous ventricular septal rupture closure post myocardial infarction, uncover the strategies and techniques used to manage these complex situations....
Aortic valve disease – Imaging strategies for optimal valve selection and outcomes in TAVI
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
Dive into this in-depth session on aortic valve disease, covering essential imaging insights for selecting the ideal TAVI prosthesis, identifying risk markers for pacemaker implantation, and optimizing outcomes in complex cases. Learn how multi-modality imaging aids in diagnosing and managing bioprosthetic valve dysfunction, including detecting patient-prosthesis...
Navigating complexities in multivalvular heart disease: risk stratification, intervention timing, and advanced imaging
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session explores the challenges of managing mixed and multiple valvular heart diseases, focusing on risk stratification, treatment decisions, and transcatheter intervention timing. Experts discuss assessing and treating aortic and mitral paravalvular leaks, as well as managing mitral annular calcification, using case studies to guide optimal...
POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?
02 Sep 2024
Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.

Author
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction
03 Apr 2022
Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.

Author
Transcatheter aortic valve replacement for asymptomatic severe aortic stenosis: Results of the EARLY TAVR trial
29 Oct 2024
Luigi Biasco provides his take on the results of the EARLY TAVR trial, presented by Philippe Genereux at TCT 2024 in Washington.

Author
Transcatheter aortic valve replacement in small aortic annuli: Results from the FRANCE-TAVI registry
17 Sep 2022
Mirvat Alasnag provides her take on the outcomes of small annuli sub-study from the FRANCE-TAVI Registry which included 1,195 patients. This trial was presented by Walid Ben-Ali at TCT 2022.

Author
ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI
28 Mar 2026
Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.

Author
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome
03 Sep 2025
Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author
TRILUMINATE pivotal: A landmark randomized clinical trial of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation
04 Mar 2023
Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).

Author

Author
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.

Author
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial
29 Mar 2025
Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.

Author